1.1 	A bill for an act
1.2 	relating to human services; requiring the commissioner of human services to 
1.3 	conduct a prescription digital therapeutics pilot project; requiring a report; 
1.4 	appropriating money.
1.5 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

1.6 	Section 1. PRESCRIPTION DIGITAL THERAPEUTICS PILOT PROJECT.
 1.7 	(a) The commissioner of human services must conduct a pilot project to explore the 
1.8 	effectiveness of prescription digital therapeutics (PDTs) in treating medical assistance 
1.9 	enrollees for substance use disorders and opioid use disorders. The pilot project must include 
1.10 	at least one clinic or practice site in the seven-county metropolitan area and at least one 
1.11 	clinic or practice site in greater Minnesota. The pilot project must allow the clinics or practice 
1.12 	sites to incorporate PDTs in the treatment plans for substance use disorders and opioid use 
1.13 	disorders for up to 12 weeks, in addition to treatment with medication and behavioral health 
1.14 	services, for up to 400 aggregate medical assistance enrollees. The enrollees participating 
1.15 	must reflect diverse population demographics. Participation by medical assistance enrollees 
1.16 	is voluntary. The participating clinics or practice sites must seek informed consent from 
1.17 	enrollees for participation in the pilot project, along with any necessary independent research 
1.18 	board approvals. The clinic or practice site must notify the commissioner of the enrollees 
1.19 	participating in the pilot project.
1.20 	(b) The commissioner must submit a report on the pilot project to the chairs and ranking 
1.21 	minority members of the legislative committees with jurisdiction over health and human 
1.22 	services finance and policy by September 30, 2025. The report must:
1.23 	(1) describe the characteristics of the population included in the pilot project;
2.1 	(2) describe the successes and challenges of the pilot project;
2.2 	(3) analyze the effect of the pilot project on access to treatment, patient satisfaction, 
2.3 	successful completion of treatment goals, and health equity;
2.4 	(4) compare the hospitalization rates of the pilot population with that of medical assistance 
2.5 	enrollees with substance use disorders or opioid use disorders who did not utilize PDTs in 
2.6 	their treatment plans; and
2.7 	(5) provide recommendations on whether PDT coverage for the treatment of substance 
2.8 	use disorders or opioid use disorders should be included under the medical assistance 
2.9 	program.

2.10 	Sec. 2. APPROPRIATION.
 2.11 	$....... in fiscal year 2023 is appropriated from the general fund to the commissioner of 
2.12 	human services to establish and implement a prescription digital therapeutics pilot project 
2.13 	under section 1. The commissioner may use up to $....... of this appropriation for staffing 
2.14 	and administrative costs. Appropriated money may be expended until exhausted or through 
2.15 	January 1, 2025, whichever is earlier.